| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005649 | Clinical Therapeutics | 2005 | 14 Pages |
Abstract
In this study, the RSG/MET fixed-dose1026 combination (8 mg/2 g per day) was an effective and well-tolerated treatment for type 2 DM and enabled more patients to reach glycemic targets than high-dose MET (3 g/d)
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
PhD FRCP(Edin), FRCPath Bailey, MD PhD Bagdonas, MD Rubes, PhD McMorn, PhD Donaldson, PhD Biswas, DM FRCP Stewart,